Citation: E. Bjork et al., INDUCTION OF BETA-CELL REST IN TYPE-1 DIABETES - STUDIES ON THE EFFECTS OF OCTREOTIDE AND DIAZOXIDE, Diabetes care, 21(3), 1998, pp. 427-430
Authors:
PUUMALA T
BJORKLUND M
RUOTSALAINEN S
RIEKKINEN M
JAKALA P
HAAPALINNA A
BJORK E
RIEKKINEN P
SIRVIO J
Citation: T. Puumala et al., LACK OF RELATIONSHIP BETWEEN THALAMIC OSCILLATIONS AND ATTENTION IN RATS - DIFFERENTIAL MODULATION BY AN ALPHA-2 ANTAGONIST, Brain research bulletin, 43(2), 1997, pp. 163-171
Citation: Aw. Larhed et al., DIFFUSION OF DRUGS IN NATIVE AND PURIFIED GASTROINTESTINAL MUCUS, Journal of pharmaceutical sciences, 86(6), 1997, pp. 660-665
Citation: C. Bjerre et al., BIOAVAILABILITY OF THE SEDATIVE PROPIOMAZINE AFTER NASAL ADMINISTRATION IN RATS, International journal of pharmaceutics, 144(2), 1996, pp. 217-224
Authors:
BJORK E
BERNE C
KAMPE O
WIBELL L
OSKARSSON P
KARLSSON FA
Citation: E. Bjork et al., DIAZOXIDE TREATMENT IN ADULTS WITH NEWLY-ONSET AUTOIMMUNE DIABETES IMPROVED RESIDUAL INSULIN-SECRETION, Diabetes, 45, 1996, pp. 736-736
Authors:
BJORK E
BERNE C
KAMPE O
WIBELL L
OSKARSSON P
KARLSSON FA
Citation: E. Bjork et al., DIAZOXIDE TREATMENT AT ONSET PRESERVES RESIDUAL INSULIN-SECRETION IN ADULTS WITH AUTOIMMUNE DIABETES, Diabetes, 45(10), 1996, pp. 1427-1430
Citation: E. Bjork et al., STARCH MICROSPHERES INDUCE PULSATILE DELIVERY OF DRUGS AND PEPTIDES ACROSS THE EPITHELIAL BARRIER BY REVERSIBLE SEPARATION OF THE TIGHT JUNCTIONS, Journal of drug targeting., 2(6), 1995, pp. 501-507
Authors:
RORSMAN F
HUSEBYE ES
WINQVIST O
BJORK E
KARLSSON FA
KAMPE O
Citation: F. Rorsman et al., AROMATIC-L-AMINO-ACID DECARBOXYLASE, A PYRIDOXAL PHOSPHATE-DEPENDENT ENZYME, IS A BETA-CELL AUTOANTIGEN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(19), 1995, pp. 8626-8629
Authors:
BJORK E
BERNE C
KAMPE O
WIBELL L
OSKARSSON P
KARLSSON FA
Citation: E. Bjork et al., DIAZOXIDE TREATMENT IN ADULTS WITH NEWLY-ONSET AUTOIMMUNE DIABETES IMPROVED RESIDUAL INSULIN-SECRETION AT A ONE-YEAR FOLLOW-UP, Diabetologia, 38, 1995, pp. 99-99
Authors:
VELLOSO LA
BJORK E
BALLAGI AE
FUNA K
ANDERSSON A
KAMPE O
KARLSSON FA
EIZIRIK DL
Citation: La. Velloso et al., REGULATION OF GAD EXPRESSION IN ISLETS OF LANGERHANS OCCURS BOTH AT THE MESSENGER-RNA AND PROTEIN LEVEL, Molecular and cellular endocrinology, 102(1-2), 1994, pp. 31-37
Citation: E. Bjork et al., GAD AUTOANTIBODIES IN IDDM, STIFF-MAN SYNDROME, AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE-I RECOGNIZE DIFFERENT EPITOPES, Diabetes, 43(1), 1994, pp. 161-165
Authors:
BJORK E
KAMPE O
GRAWE J
HALLBERG A
NORHEIM I
KARLSSON FA
Citation: E. Bjork et al., MODULATION OF BETA-CELL ACTIVITY AND ITS INFLUENCE ON ISLET-CELL ANTIBODY (ICA) AND ISLET-CELL SURFACE ANTIBODY (ICSA) REACTIVITY, Autoimmunity, 16(3), 1993, pp. 181-188
Authors:
VELLOSO LA
BJORK E
BALLAGIPORDANY A
FUNA K
ANDERSSON A
KAMPE O
KARLSSON FA
EIZIRIK DL
Citation: La. Velloso et al., HIGH GLUCOSE STIMULATES GAD MESSENGER-RNA EXPRESSION AND ENZYME-ACTIVITY IN ISLETS OF LANGERHANS, Diabetologia, 36, 1993, pp. 10000010-10000010
Citation: E. Bjork et al., DIFFERENCES IN EPITOPE SELECTION AMONG GAD-AUTOANTIBODIES IN INSULIN-DEPENDENT DIABETES, STIFF-MAN SYNDROME AND AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE-I, Diabetologia, 36, 1993, pp. 10000024-10000024